Sun Pharmaceutical Industries Limited

NSEI:SUNPHARMA Stock Report

Market Cap: ₹4.4t

Sun Pharmaceutical Industries Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SUNPHARMA?
Owner TypeNumber of SharesOwnership Percentage
State or Government30,283,4381.26%
Individual Insiders288,200,51312%
General Public378,314,75615.8%
Institutions659,183,74427.5%
Private Companies1,043,352,51943.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
40.3%
Shanghvi Finance Pvt Ltd
967,051,732₹1.8t0%no data
9.6%
Dilip Shanghvi
230,385,155₹419.1b0%no data
3.4%
ICICI Prudential Asset Management Company Limited
81,459,113₹148.2b-16.5%2.61%
3.14%
Life Insurance Corporation of India, Asset Management Arm
75,428,838₹137.2b1.38%0.94%
2.18%
SBI Funds Management Limited
52,293,622₹95.1b3.84%1.21%
1.82%
The Vanguard Group, Inc.
43,578,883₹79.3b0.53%0.01%
1.8%
Sudhir Valia
43,175,371₹78.5b0%no data
1.67%
Shanghvi Finance Private Limited
40,153,960₹73.0b0%no data
1.55%
BlackRock, Inc.
37,212,011₹67.7b-0.8%0.01%
1.17%
Nps Trust
28,122,695₹51.2b0%4.03%
1.17%
Hdfc Standard Life Insurance Company Limited, Asset Management Arm
28,055,294₹51.0b-1.43%6.85%
1.15%
Singapore
27,520,426₹50.1b0%no data
1.05%
GQG Partners LLC
25,152,249₹45.8b6.79%0.44%
1.03%
HDFC Asset Management Company Limited
24,828,996₹45.2b2.08%0.96%
1.02%
Lakshdeep Investments & Finance Pvt. Ltd
24,418,497₹44.4b0%no data
1.01%
Norges Bank Investment Management
24,243,900₹44.1b-3.06%0.04%
0.79%
Aditya Birla Sun Life AMC Limited
18,946,982₹34.5b-0.36%1.88%
0.77%
Nippon Life India Asset Management Limited
18,423,932₹33.5b-2.52%0.86%
0.72%
UTI Asset Management Company Limited
17,289,421₹31.4b1.99%1.19%
0.65%
Axis Asset Management Company Limited
15,541,977₹28.3b3.35%1.32%
0.49%
Kotak Mahindra Asset Management Company Limited
11,693,555₹21.3b10.5%0.73%
0.43%
Unimed Investments Limited
10,400,850₹18.9b0%no data
0.37%
Goldman Sachs Asset Management, L.P.
8,891,680₹16.2b-0.05%0.05%
0.37%
Vibha Shanghvi
8,840,280₹16.1b0%no data
0.35%
Franklin Resources, Inc.
8,422,686₹15.3b1.16%0.06%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 02:50
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sun Pharmaceutical Industries Limited is covered by 73 analysts. 36 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Prashant NairAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited